144 related articles for article (PubMed ID: 23222122)
1. Head and neck adenoid cystic carcinoma: what is new in biological markers and treatment?
Bell D; Hanna EY
Curr Opin Otolaryngol Head Neck Surg; 2013 Apr; 21(2):124-9. PubMed ID: 23222122
[TBL] [Abstract][Full Text] [Related]
2. New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.
Bhaijee F; Pepper DJ; Pitman KT; Bell D
Ann Diagn Pathol; 2011 Feb; 15(1):69-77. PubMed ID: 21238915
[TBL] [Abstract][Full Text] [Related]
3. Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma.
Persson M; Andrén Y; Moskaluk CA; Frierson HF; Cooke SL; Futreal PA; Kling T; Nelander S; Nordkvist A; Persson F; Stenman G
Genes Chromosomes Cancer; 2012 Aug; 51(8):805-17. PubMed ID: 22505352
[TBL] [Abstract][Full Text] [Related]
4. MYB-NFIB Translocation by FISH in Adenoid Cystic Carcinoma of the Head and Neck in Nigerian Patients: A Preliminary Report.
Owosho AA; Adesina OM; Odujoko O; Soyele OO; Komolafe A; Bauer R; Holte K; Summersgill KF
Head Neck Pathol; 2021 Jun; 15(2):433-437. PubMed ID: 32857249
[TBL] [Abstract][Full Text] [Related]
5. The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma.
Fehr A; Kovács A; Löning T; Frierson H; van den Oord J; Stenman G
J Pathol; 2011 Jul; 224(3):322-7. PubMed ID: 21618541
[TBL] [Abstract][Full Text] [Related]
6. Adenoid cystic carcinoma of the head and neck--An update.
Coca-Pelaz A; Rodrigo JP; Bradley PJ; Vander Poorten V; Triantafyllou A; Hunt JL; Strojan P; Rinaldo A; Haigentz M; Takes RP; Mondin V; Teymoortash A; Thompson LD; Ferlito A
Oral Oncol; 2015 Jul; 51(7):652-61. PubMed ID: 25943783
[TBL] [Abstract][Full Text] [Related]
7. MYB-NFIB fusion transcript in adenoid cystic carcinoma: Current state of knowledge and future directions.
Wagner VP; Bingle CD; Bingle L
Crit Rev Oncol Hematol; 2022 Aug; 176():103745. PubMed ID: 35738530
[TBL] [Abstract][Full Text] [Related]
8. t(6;9)(MYB-NFIB) in head and neck adenoid cystic carcinoma: A systematic review with meta-analysis.
de Almeida-Pinto YD; Costa SFDS; de Andrade BAB; Altemani A; Vargas PA; Abreu LG; Fonseca FP
Oral Dis; 2019 Jul; 25(5):1277-1282. PubMed ID: 30269389
[TBL] [Abstract][Full Text] [Related]
9. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.
Persson M; Andrén Y; Mark J; Horlings HM; Persson F; Stenman G
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18740-4. PubMed ID: 19841262
[TBL] [Abstract][Full Text] [Related]
10. MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features.
D'Alfonso TM; Mosquera JM; MacDonald TY; Padilla J; Liu YF; Rubin MA; Shin SJ
Hum Pathol; 2014 Nov; 45(11):2270-80. PubMed ID: 25217885
[TBL] [Abstract][Full Text] [Related]
11. Ongoing challenges in the treatment of adenoid cystic carcinoma of the head and neck.
Subramaniam T; Lennon P; O'Neill JP
Ir J Med Sci; 2015 Sep; 184(3):583-90. PubMed ID: 25894281
[TBL] [Abstract][Full Text] [Related]
12. Frequent NFIB-associated Gene Rearrangement in Adenoid Cystic Carcinoma of the Vulva.
Xing D; Bakhsh S; Melnyk N; Isacson C; Ho J; Huntsman DG; Gilks CB; Ronnett BM; Horlings HM
Int J Gynecol Pathol; 2017 May; 36(3):289-293. PubMed ID: 27662035
[TBL] [Abstract][Full Text] [Related]
13. Treatment and clinicopathologic predictors for adenoid cystic carcinomas of the head and neck.
Ozdemir C; Karacetin D; Tuna S; Karadeniz A
J BUON; 2011; 16(1):123-6. PubMed ID: 21674862
[TBL] [Abstract][Full Text] [Related]
14. [Adenoid cystic carcinoma of the head and neck: a retrospective series of 169 cases].
Dubergé T; Bénézery K; Resbeut M; Azria D; Minsat M; Ellis S; Teissier E; Zaccariotto A; Champetier C; Cowen D
Cancer Radiother; 2012; 16(4):247-56. PubMed ID: 22652299
[TBL] [Abstract][Full Text] [Related]
15. Adenoid cystic carcinoma: clinical and molecular features.
Moskaluk CA
Head Neck Pathol; 2013 Mar; 7(1):17-22. PubMed ID: 23463073
[TBL] [Abstract][Full Text] [Related]
16. Adenoid cystic carcinoma of the head and neck: a review.
Bradley PJ
Curr Opin Otolaryngol Head Neck Surg; 2004 Apr; 12(2):127-32. PubMed ID: 15167050
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.
Ross JS; Wang K; Rand JV; Sheehan CE; Jennings TA; Al-Rohil RN; Otto GA; Curran JC; Palmer G; Downing SR; Yelensky R; Lipson D; Balasubramanian S; Garcia L; Mahoney K; Ali SM; Miller VA; Stephens PJ
Am J Surg Pathol; 2014 Feb; 38(2):235-8. PubMed ID: 24418857
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous adenoid cystic carcinoma with MYB aberrations: report of three cases and comprehensive review of the literature.
Prieto-Granada CN; Zhang L; Antonescu CR; Henneberry JM; Messina JL
J Cutan Pathol; 2017 Feb; 44(2):201-209. PubMed ID: 27859477
[TBL] [Abstract][Full Text] [Related]
19. MYB-fusions and other potential actionable targets in adenoid cystic carcinoma.
Ferrarotto R; Heymach JV; Glisson BS
Curr Opin Oncol; 2016 May; 28(3):195-200. PubMed ID: 26974847
[TBL] [Abstract][Full Text] [Related]
20. Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials.
Dillon PM; Chakraborty S; Moskaluk CA; Joshi PJ; Thomas CY
Head Neck; 2016 Apr; 38(4):620-7. PubMed ID: 25487882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
